Performance Evaluation of an Ultra-Sensitive Assay for NSCLC Biomarker Testing

Home > Science Hub > Performance Evaluation of an Ultra-Sensitive Assay for NSCLC Biomarker Testing
Back to the list

June 23, 2025

Nathalie Bernard¹, Magdalena Stolarek-Januszkiewicz², Christina Xyrafaki², Ana-Luisa Silva², Justyna Mordaka², Sara Diels¹, Dirk Goossens¹, Lien Heyrman¹, Bart Tegenbos¹, Jurgen Del Favero

You might also be interested by

Posters

Advancing B-Cell Monitoring in B-Cell-Depleting Therapies for Autoimmune Disorders

June 8, 2026

More info

Uncategorized

Accelerating spectral flow cytometry assay development for clinical trials with a flexible panel design

June 8, 2026

More info

News

Leica Biosystems and CellCarta Expand Collaborative Companion Diagnostic Development Model to Accelerate Commercialization Globally

May 29, 2026

More info

News

CellCarta and Sonic Healthcare Establish Strategic Partnership to Commercialize Companion Diagnostics Through Lab Network

May 27, 2026

More info